Anakinra Therapy for Non-cancer Inflammatory Diseases (vol 9, 1157, 2018)

被引：6

作者：

Cavalli, Giulio ^{[1
,2
]}

Dinarello, Charles A. ^{[2
,3
]}

机构：

[1] Univ Vita Salute San Raffaele, Hosp San Raffaele, Unit Immunol Rheumatol Allergy & Rare Dis, Milan, Italy

[2] Radboud Univ Nijmegen, Med Ctr, Dept Med, Nijmegen, Netherlands

[3] Univ Colorado Denver, Dept Med, Denver, CO 80204 USA

来源：

FRONTIERS IN PHARMACOLOGY | 2019年 / 10卷

关键词：

interleukin; 1; IL-1; beta; alpha; rheumatology; inflammation; INTERLEUKIN-1;

D O I：

10.3389/fphar.2019.00148

中图分类号：

R9 [药学];

学科分类号：

1007 ;

摘要：

引用

页数：2

共 6 条

[1] PROSTAGLANDIN-E2 AND COLLAGENASE PRODUCTION BY FIBROBLASTS AND SYNOVIAL-CELLS IS REGULATED BY URINE-DERIVED HUMAN INTERLEUKIN-1 AND INHIBITOR(S) [J].

BALAVOINE, JF ;

DEROCHEMONTEIX, B ;

WILLIAMSON, K ;

SECKINGER, P ;

CRUCHAUD, A ;

DAYER, JM .

JOURNAL OF CLINICAL INVESTIGATION, 1986, 78 (04) :1120-1124

[2]

BALAVOINE JF, 1984, LYMPHOKINE RES, V3, P233

[3] Anakinra Therapy for Non-cancer Inflammatory Diseases [J].

Cavalli, Giulio ;

Dinarello, Charles A. .

FRONTIERS IN PHARMACOLOGY, 2018, 9

[4]

DINARELLO CA, 1981, J IMMUNOL, V127, P2517

[5] PRODUCTION OF INTERLEUKIN-1-RECEPTOR ANTAGONIST DURING EXPERIMENTAL ENDOTOXEMIA [J].

GRANOWITZ, EV ;

SANTOS, AA ;

POUTSIAKA, DD ;

CANNON, JG ;

WILMORE, DW ;

WOLFF, SM ;

DINARELLO, CA .

LANCET, 1991, 338 (8780) :1423-1424

[6]

SECKINGER P, 1987, J IMMUNOL, V139, P1546

← 1 →